Skip to Main Content
The University of Arizona Health Sciences

Managing NIH Public Access Compliance: Cite using PMCIDs

This guide explains the NIH Public Access Policy, the process for submitting peer-reviewed articles to PubMed Central and how to use NIH tools to manage and verify compliance.

Finding PMCIDs

Go to PubMed Central to find the PMCID/PMID/ NIHMSID Converter.

Submit one or a set of PubMed IDs (PMIDs) and get the corresponding PMCIDs and/or NIHMS IDs if they exist.

How to submit publications with the RPPR

First ensure your MyNCBI account is linked to your eRA Commons account

Use My Bibliography (located in MyNCBI) to generate a PDF of publications to submit with your Research Performance Progress Reports.

RPPR FAQs

PRAM (Public Access Progress Report Additional Materials)

Show evidence of compliance

NIH logoIn NIH applications, proposals, and progress reports, show compliance by including one of the following at the end of a citation:

  • PubMed Central identification #(PMCID)​

  • NIH Manuscript Submission indentification # (NIHMSID)​

  • "PMC Journal - In Process"

This applies to articles that fall under the Policy and are authored or co-authored by you or arose from your NIH award. See more information.

Examples:

Assigned PMCID

Ports MO, Nagle RB, Pond GD, Cress AE. Extracellular engagement of alpha6 integrin inhibited urokinase-type plasminogen activator-mediated cleavage and delayed human prostate bone metastasis. Cancer Res. 2009 Jun 15;69(12):5007-14. PMC2697270

In Process: use for Submission Methods A & B (within 3 months of publication)

Ports MO, Nagle RB, Pond GD, Cress AE. Extracellular engagement of alpha6 integrin inhibited urokinase-type plasminogen activator-mediated cleavage and delayed human prostate bone metastasis. Cancer Res. 2009 Jun 15;69(12):5007-14. In Press.

PMC Journal - In Process 

In Process: use assigned NIHMSID for Submission Methods C & D (within 3 months of publication)
Ports MO, Nagle RB, Pond GD, Cress AE. Extracellular engagement of alpha6 integrin inhibited urokinase-type plasminogen activator-mediated cleavage and delayed human prostate bone metastasis. Cancer Res. 2009 Jun 15;69(12):5007-14. NIHMS112418  

Note: NIH awardees are responsible for ensuring that all steps of the NIHMS submission process are complete, including having the PMCID assigned, within three months of the publication of the article. Articles are noncompliant if they do not have a PMCID three months after the publication date.